Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Neurochemical Research
|
May 27, 2022
Rho-Rho-Kinase Regulates Ras-ERK Signaling Through SynGAP1 for Dendritic Spine Morphology
Mengya Wu, Yasuhiro Funahashi, Tetsuya Takano, et al.
Molecules (Basel, Switzerland)
|
January 11, 2024
Preparations of <i>trans</i>- and <i>cis</i>-<i>μ</i>-1,2-Peroxodiiron(III) Complexes
Yuji Kajita, Masaki Kubo, Hidekazu Arii, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization
Kiyoshi Okamoto, Megumi Ikemori-Kawada, Anja Jestel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 17, 2003
Combined effects of electrostatic and pi-pi stacking interactions: selective binding of nucleotides and aromatic carboxylates by platinum(II)-aromatic ligand complexes
Tatsuo Yajima, Giuseppe Maccarrone, Masako Takani, et al.
Frontiers in Molecular Neuroscience
|
April 17, 2024
KANPHOS: Kinase-associated neural phospho-signaling database for data-driven research
Takayuki Kannon, Satoshi Murashige, Tomoki Nishioka, et al.
Biochemical and Biophysical Research Communications
|
April 5, 2019
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades
Taisuke Hoshi, Saori Watanabe Miyano, Hideki Watanabe, et al.
Journal of Neurochemistry
|
August 8, 2009
CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity
Nariko Arimura, Atsushi Hattori, Toshihide Kimura, et al.
Cancer Science
|
January 21, 2017
Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus
Masahiro Matsuki, Yusuke Adachi, Yoichi Ozawa, et al.
Molecular Cancer Therapeutics
|
October 10, 2023
Amelioration of Tumor-promoting Microenvironment via Vascular Remodeling and CAF Suppression Using E7130: Biomarker Analysis by Multimodal Imaging Modalities
Ken Ito, Masayuki Yamaguchi, Taro Semba, et al.
Molecular Cancer Therapeutics
|
January 25, 2023
Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody
Yuki Niwa, Keito Adachi, Kimiyo Tabata, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Neurochemical Research
|
May 27, 2022
Rho-Rho-Kinase Regulates Ras-ERK Signaling Through SynGAP1 for Dendritic Spine Morphology
Mengya Wu, Yasuhiro Funahashi, Tetsuya Takano, et al.
Molecules (Basel, Switzerland)
|
January 11, 2024
Preparations of <i>trans</i>- and <i>cis</i>-<i>μ</i>-1,2-Peroxodiiron(III) Complexes
Yuji Kajita, Masaki Kubo, Hidekazu Arii, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization
Kiyoshi Okamoto, Megumi Ikemori-Kawada, Anja Jestel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
July 17, 2003
Combined effects of electrostatic and pi-pi stacking interactions: selective binding of nucleotides and aromatic carboxylates by platinum(II)-aromatic ligand complexes
Tatsuo Yajima, Giuseppe Maccarrone, Masako Takani, et al.
Frontiers in Molecular Neuroscience
|
April 17, 2024
KANPHOS: Kinase-associated neural phospho-signaling database for data-driven research
Takayuki Kannon, Satoshi Murashige, Tomoki Nishioka, et al.
Biochemical and Biophysical Research Communications
|
April 5, 2019
Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades
Taisuke Hoshi, Saori Watanabe Miyano, Hideki Watanabe, et al.
Journal of Neurochemistry
|
August 8, 2009
CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity
Nariko Arimura, Atsushi Hattori, Toshihide Kimura, et al.
Cancer Science
|
January 21, 2017
Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus
Masahiro Matsuki, Yusuke Adachi, Yoichi Ozawa, et al.
Molecular Cancer Therapeutics
|
October 10, 2023
Amelioration of Tumor-promoting Microenvironment via Vascular Remodeling and CAF Suppression Using E7130: Biomarker Analysis by Multimodal Imaging Modalities
Ken Ito, Masayuki Yamaguchi, Taro Semba, et al.
Molecular Cancer Therapeutics
|
January 25, 2023
Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody
Yuki Niwa, Keito Adachi, Kimiyo Tabata, et al.
Page
of 13